BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2533411)

  • 1. Changes in maximum expiratory flow-volume curve configuration after treatment with inhaled corticosteroids.
    Kraan J; van der Mark TW; Koëter GH
    Thorax; 1989 Dec; 44(12):1015-21. PubMed ID: 2533411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
    Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
    Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
    Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
    Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects.
    Bel EH; Timmers MC; Zwinderman AH; Dijkman JH; Sterk PJ
    Am Rev Respir Dis; 1991 Jan; 143(1):109-13. PubMed ID: 1986667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on airway reversibility test by ipratropium bromide (Sch 1000) inhalation using partial and maximum expiratory flow-volume curve].
    Shibayama M; Kawai K; Matsubara F; Fujimura M; Ishizaki T; Miyabo S
    Rinsho Byori; 1984 Mar; 32(3):317-22. PubMed ID: 6234409
    [No Abstract]   [Full Text] [Related]  

  • 8. Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.
    Groggins RC; Milner AD; Stokes GM
    Arch Dis Child; 1981 May; 56(5):342-4. PubMed ID: 6455096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of perennial secretory rhinitis.
    Bende M; Rundcrantz H
    ORL J Otorhinolaryngol Relat Spec; 1985; 47(6):303-6. PubMed ID: 2934671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma: comparative bronchodilator effects of ipratropium bromide and isoproterenol.
    Yeager H; Weinberg RM; Kaufman LV; Katz S
    J Clin Pharmacol; 1976 Apr; 16(4):198-204. PubMed ID: 131133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the bronchodilatation of ipratropium bromide and fenoterol nebuliser solutions administered alone and in combination.
    Shneerson JM
    Respiration; 1986; 50 Suppl 2():274-5. PubMed ID: 2951820
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined therapy with ipratropium and theophylline in asthma.
    Kreisman H; Cohen C; Ghezzo H; Vickerson F; Frank H; Wolkove N
    Ann Allergy; 1984 Feb; 52(2):90-3. PubMed ID: 6230034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma.
    Partridge MR; Saunders KB
    Thorax; 1981 Jul; 36(7):530-3. PubMed ID: 6458921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance.
    Taylor RG; Pavia D; Agnew JE; Lopez-Vidriero MT; Newman SP; Lennard-Jones T; Clarke SW
    Thorax; 1986 Apr; 41(4):295-300. PubMed ID: 2943050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between the grade of methacholine-induced bronchial hyperreactivity and ipratropium bronchodilation in asthmatics.
    Hedenström H; Wegener T
    Ups J Med Sci; 1988; 93(1):71-80. PubMed ID: 2967576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study.
    Burke CM; Sreenan S; Pathmakanthan S; Patterson J; Schmekel B; Poulter LW
    Thorax; 1996 Oct; 51(10):993-9. PubMed ID: 8977599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipratropium bromide in acute asthma.
    Ward MJ; Fentem PH; Smith WH; Davies D
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):598-600. PubMed ID: 6451257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in pulmonary function and cross-sectional area of trachea and bronchi in asthmatics following inhalation of procaterol hydrochloride and ipratropium bromide.
    Hoffstein V; Zamel N; McClean P; Chapman KR
    Am J Respir Crit Care Med; 1994 Jan; 149(1):81-5. PubMed ID: 8111604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilating and density dependence effects of fenoterol, ipratropium bromide and Duovent in reversible chronic obstructive pulmonary disease.
    Dubois PE; Delwiche JP; Minette P; Lulling J; Prignot J
    Respiration; 1986; 50 Suppl 2():280-4. PubMed ID: 2951822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of asthma bronchiale with a combination of ipratropium bromide and fenoterol.
    Sahlström K; Alanko K; Härkönen R
    Respiration; 1986; 50 Suppl 2():302-9. PubMed ID: 2951826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.